Medicare Enrolled
Dr. Amit Barochia, MD
Hematology · Melbourne, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Barochia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barochia? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barochia
Dr. Amit Barochia is a hematology in Melbourne, FL, with 18 years in practice. Based on federal Medicare data, Dr. Barochia performed 190,429 Medicare services across 3,886 unique beneficiaries.
Between the years covered by Open Payments, Dr. Barochia received a total of $6,052 from 53 pharmaceutical and/or device companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barochia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 23% volume in FL$ $6,052 industry payments
Medicare Practice Summary
Medicare Utilization ↗190,429
Medicare services
Top 23% in FL for hematology
3,886
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,579 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 36,210 | $0 | $3 |
| Iron infusion (Injectafer) | 36,000 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 25,600 | $42 | $105 |
| Azacitidine chemotherapy injection | 14,934 | $0 | $3 |
| Anti-nausea injection (fosaprepitant) | 14,700 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 12,540 | $18 | $45 |
| Iron sucrose injection (Venofer) | 12,000 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia | 9,380 | $6 | $21 |
| Immune globulin infusion (Gammagard) | 7,980 | $36 | $89 |
| Golimumab infusion (Simponi Aria) | 4,710 | $10 | $42 |
| Dexamethasone injection (steroid) | 2,540 | $0 | $0 |
| Office visit, established patient (30-39 min) | 2,362 | $92 | $255 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,660 | $1 | $27 |
| Drug injection, under skin or into muscle | 696 | $10 | $42 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 684 | $81 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 676 | $0 | $1 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 639 | $22 | $57 |
| Office visit, established patient, complex (40-54 min) | 626 | $133 | $358 |
| Administration of chemotherapy into vein, 1 hour or less | 561 | $97 | $256 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 534 | $46 | $133 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 433 | $134 | $1,054 |
| Injection, fulvestrant, 25 mg | 400 | $8 | $161 |
| Injection, potassium chloride, per 2 meq | 380 | $0 | $0 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 294 | $15 | $41 |
| Injection, diphenhydramine hcl, up to 50 mg | 281 | $1 | $3 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 272 | $54 | $142 |
| Injection, magnesium sulfate, per 500 mg | 260 | $1 | $2 |
| Hospital follow-up visit, high complexity | 256 | $93 | $235 |
| Injection of additional new drug or substance into vein | 251 | $12 | $36 |
| Hospital follow-up visit, moderate complexity | 188 | $62 | $157 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 186 | $25 | $66 |
| Office visit, established patient (20-29 min) | 178 | $65 | $180 |
| Infusion, normal saline solution , 1000 cc | 157 | $2 | $6 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 152 | $1 | $5 |
| New patient office visit (45-59 min) | 144 | $114 | $335 |
| Collection of blood sample from implanted device | 143 | $19 | $52 |
| Initial hospital admission, high complexity | 142 | $134 | $361 |
| Administration of chemotherapy into vein, each additional hour | 139 | $21 | $56 |
| Injection, zoledronic acid, 1 mg | 129 | $6 | $29 |
| Irrigation of implanted venous access drug delivery device | 115 | $18 | $50 |
| New patient office visit, complex (60-74 min) | 105 | $171 | $442 |
| Infusion into a vein for hydration, each additional hour | 97 | $10 | $25 |
| Red blood cells, leukocytes reduced, each unit | 97 | $67 | $564 |
| Administration of additional new drug or substance into vein, 1 hour or less | 95 | $49 | $127 |
| Transfusion of blood or blood products | 91 | $29 | $76 |
| Infusion into a vein for hydration, 31-60 minutes | 78 | $24 | $96 |
| Drawing of blood for a medical problem | 65 | $65 | $190 |
| Application of on-body injector for under skin injection | 58 | $14 | $37 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 56 | $4 | $13 |
| Injection, alteplase recombinant, 1 mg | 52 | $69 | $177 |
| Administration of additional new drug or substance into vein using push technique | 50 | $42 | $109 |
| Declotting of central venous tube | 22 | $24 | $64 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 16 | $270 | $700 |
| Initial hospital admission, moderate complexity | 15 | $103 | $266 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
45.6% high complexity
51.8% medium
2.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,052
Total received (2018-2024)
Avg $865/year across 7 years
Bottom 44% in FL for hematology
53
Companies
298
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,387 (89.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$664 (11.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$141
2023$202
2022$1,036
2021$1,213
2020$1,174
2019$1,369
2018$917
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$658
Amgen Inc.
$651
AstraZeneca Pharmaceuticals LP
$464
Celgene Corporation
$401
PFIZER INC.
$375
Seagen Inc.
$295
Merck Sharp & Dohme Corporation
$280
Lilly USA, LLC
$256
Janssen Biotech, Inc.
$246
GENZYME CORPORATION
$187
Bayer HealthCare Pharmaceuticals Inc.
$180
Daiichi Sankyo Inc.
$179
Genentech USA, Inc.
$173
Cardiovascular Systems Inc.
$152
E.R. Squibb & Sons, L.L.C.
$149
Incyte Corporation
$142
Kite Pharma, Inc.
$124
Novocure Inc.
$119
Takeda Pharmaceuticals U.S.A., Inc.
$83
TOLMAR Pharmaceuticals, Inc.
$55
Global Blood Therapeutics, Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
ARRAY BIOPHARMA INC
$46
EISAI INC.
$45
Astellas Pharma US Inc
$45
MorphoSys, US Inc.
$45
Pharmacyclics LLC, An AbbVie Company
$43
Sun Pharmaceutical Industries Inc.
$37
PUMA BIOTECHNOLOGY, INC.
$33
Kyowa Kirin, Inc.
$31
Regeneron Healthcare Solutions, Inc.
$30
Jazz Pharmaceuticals Inc.
$28
JAZZ PHARMACEUTICALS INC.
$27
Sobi, Inc
$27
ADC Therapeutics America, Inc.
$26
Gilead Sciences, Inc.
$24
TESARO, Inc.
$23
Verastem, Inc.
$23
Mirati Therapeutics, Inc.
$21
Myriad Genetic Laboratories, Inc.
$20
Pharmacosmos Therapeutics Inc.
$18
BeiGene USA, Inc.
$18
Clovis Oncology, Inc.
$17
Taiho Oncology, Inc.
$17
EMD Serono, Inc.
$17
Dendreon Pharmaceuticals LLC
$17
Seattle Genetics, Inc.
$16
Exelixis Inc.
$15
Ipsen Biopharmaceuticals, Inc
$15
GlaxoSmithKline, LLC.
$15
Puma Biotechnology, Inc.
$14
Janssen Pharmaceuticals, Inc
$13
Paratek Pharmaceuticals, Inc.
$12
Top 3 companies account for 29.3% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Alecensa · Aliqopa · Avastin · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · ELIGARD · ELITEK · ENHERTU · ERBITUX · ERLEADA · Enhertu · GILOTRIF · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · Monoferric · NERLYNX · NINLARO · NUZYRA · Nerlynx · Nplate · Nubeqa · OPDIVO · OXBRYTA · Optune · PADCEV · POTELIGEO · PROMACTA · PROSTATE CANCER - DISEASE · PROVENGE · Phesgo · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · Rubraca · SARCLISA · SCEMBLIX · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TIVDAK · TUKYSA · VERZENIO · VOTRIENT · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XTANDI · Xofigo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
10
Per 100K population
1.6
County median income
$75,817
Nearest hospital
VIERA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Barochia is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Barochia experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Barochia performed 36,210 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barochia receive payments from pharmaceutical companies?
Yes. Dr. Barochia received a total of $6,052 from 53 companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barochia's costs compare to other hematologys in Melbourne?
Dr. Barochia's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barochia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Melbourne
Browse hematologys in Melbourne ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology